Baker Bros. Advisors’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.3M | Hold |
114,833
| – | – | 0.02% | 74 |
|
|
2025
Q1 | $2.26M | Hold |
114,833
| – | – | 0.03% | 74 |
|
|
2024
Q4 | $2.58M | Hold |
114,833
| – | – | 0.03% | 81 |
|
|
2024
Q3 | $2.93M | Hold |
114,833
| – | – | 0.03% | 77 |
|
|
2024
Q2 | $2.68M | Hold |
114,833
| – | – | 0.03% | 76 |
|
|
2024
Q1 | $2.02M | Buy |
+114,833
| New | +$2.02M | 0.03% | 75 |
|